The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-8.0% to $228.00
Predicted High$254.00at 1 month
Predicted Low$228.00at 6 months
Max Drawdown (predicted)-8.0%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 23, 2026 1:17 pm
Bear
VEEV trends lower to
$228.00
(-8.0% from $247.90)
by Feb 2027.
ride-then-fade
ThesisVEEV trades at ~5x fair value but momentum, quality, and the Lilly Vault CRM narrative dominate near-term; low beta and risk-on regime keep it firm into fall, then modest valuation gravity and profit-taking bring a slow drift lower without breaking the platform story.
Invalidated ifA break below $215 on heavy volume, or a major Vault CRM customer loss/guidance cut, would falsify the ride-then-fade thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $247.90 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 23, 2026
—
$247.90at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 6, 2026
$225.36–$270.44typical range · internal point $251.50
—
±9.1%
7/10
Risk-on regime and Lilly narrative extend momentum
1 month
Sep 23, 2026
$215.24–$280.56typical range · internal point $254.00
—
±13.2%
6/10
Low-beta SaaS bid persists, no earnings catalyst
2 months
Oct 23, 2026
$248.00
—
+0.0%
5/10
Pre-earnings drift, mild profit taking near highs
3 months
Nov 23, 2026
$252.00
—
+1.7%
4/10
Likely Q3 beat continues 4-of-4 streak
4 months
Dec 23, 2026
$244.00
—
-1.6%
4/10
Year-end rotation out of expensive SaaS winners
5 months
Jan 23, 2027
$236.00
—
-4.8%
4/10
Valuation gravity begins as narrative cools
6 months
Feb 23, 2027
$228.00
—
-8.0%
4/10
Slow drift toward baseline as multiple compresses
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$211.57
(-14.7%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.